2019-11 November Newsletter
- Details
- Last Updated: 26 November 2019 26 November 2019
Dear Friend,
In this month's newsletter, a review of our annual event, congratulations to our local Ramsay Award winners, an appeal for the AMMES Financial Crisis Fund, a webinar on December 12, 2019, an announcement of the next Washington DC Lobby Day on April 21, 2020, and a reminder to download papers from the ME/CFS special issue. Read on for all the details. We wish you all a lovely Thanksgiving.
2019-10 October Newsletter
- Details
- Last Updated: 21 October 2019 21 October 2019
Annual Event 10/26/2019 -- Dr. Michael VanElzakker
- Details
- Last Updated: 19 October 2019 19 October 2019
Registration is now open for our Annual Event on Saturday, October 26th, 2019 from 1 to 4 pm at Newton-Wellesley Hospital, featuring Dr. Michael VanElzakker of MGH/Harvard Medical School. Please join us for a brief business meeting, a research presentation by Dr. VanElzakker, an update on the Harvard ME/CFS Collaboration, and a chance to meet fellow members of the Association. We look forward to seeing you! Register here.
Investigating ME/CFS at the intersection of the nervous and immune systems
Dr. Michael VanElzakker of MGH/Harvard Medical School
When: Saturday, October 26th, 2019 1:00 PM to 4:00 PM
Doors open at 12:30 p.m. for check-in
Location:
Shipley Auditorium, Bowles Conference Center
Newton Wellesley Hospital
2014 Washington St.
Newton, MA 02462
Park in the lot near the West (Main) Entrance. Directions from the parking areas to the Auditorium can be found here.
Join or renew your membership at the event! This program is open to the public and free to members of the Association, journalists, researchers and health care professionals; $15 voluntary donation for non-members.
Michael VanElzakker, PhD is a research fellow in the neurotherapeutics division of Massachusetts General Hospital / Harvard Medical School.
Dr. VanElzakker will discuss some challenges and opportunities in using brain scans to study communication between the immune and nervous systems. He will describe two ongoing studies that seek to elucidate autonomic dysfunction and possible neuroinflammation in ME/CFS. He will also give an update on the OMF-funded Harvard ME/CFS Collaboration.
Download the event flyer here! Please distribute widely.
More Articles ...
Notice about names
The Massachusetts ME/CFS & FM Association would like to clarify the use of the various acronyms for Chronic Fatigue Syndrome (CFS), Chronic Fatigue & Immune Dysfunction Syndrome (CFIDS) and Myalgic Encephalomyelitis (ME) on this site. When we generate our own articles on the illness, we will refer to it as ME/CFS, the term now generally used in the United States. When we are reporting on someone else’s report, we will use the term they use. The National Institutes of Health (NIH) and other federal agencies, including the CDC, are currently using ME/CFS.
Massachusetts ME/CFS & FM Association changed its name in July, 2018, to reflect this consensus.